BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9032500)

  • 1. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
    Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
    Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
    Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
    Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
    Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna FD; Polverino M
    J Chemother; 1997 Aug; 9(4):279-84. PubMed ID: 9269609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
    Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of dirithromycin: comparison with erythromycin.
    Bergogne-Bérézin E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dirithromycin concentrations in bronchial mucosa and secretions.
    Leroyer C; Muller-Serieys C; Quiot J; Benhamou D; Clavier J; Bergogne-Bérézin E
    Respiration; 1998; 65(5):381-5. PubMed ID: 9782221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F
    J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin.
    Bachmann K; Nunlee M; Martin M; Sullivan T; Jauregui L; DeSante K; Sides GD
    J Clin Pharmacol; 1990 Nov; 30(11):1001-5. PubMed ID: 2243147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dirithromycin in the treatment of skin and skin structure infections.
    Derriennic M; Escande JP
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():159-68. PubMed ID: 8478307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of dirithromycin in pneumonia.
    Jacobson K
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():121-9. PubMed ID: 8478303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of dirithromycin and erythromycin in bacterial pneumonia.
    Liippo K; Tala E; Puolijoki H; Brückner OJ; Rodrig J; Smits JP
    J Infect; 1994 Mar; 28(2):131-9. PubMed ID: 8034992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of dirithromycin in patients with bacteremic pneumonia.
    Hernández JM; Sides GD; Conforti PM; Smietana MG
    Clin Ther; 1996; 18(6):1128-38. PubMed ID: 9001829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM; Johns D; Sides GD
    J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of dirithromycin in pharyngitis and tonsillitis.
    Müller O; Wettich K
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():97-102. PubMed ID: 8478316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.